, is associated with decreases in plasma postheparin lipolytic activity (17, 18) . This latter finding suggests that the primary cause of the hypertriglyceridemia in fat-induced lipemia is defective removal of newly absorbed dietary chylomicrons due to deficiency in lipoprotein lipase or other tissue lipases. Although normal plasma postheparin lipolytic activity has been described in patients with carbohydrate-induced hypertriglyceridemia (1, 17) , it does not necessarily follow that the plasma lipid change must be due to endogenous overproduction. Indeed, it has recently been suggested that the cause of hypertriglyceridemia in this syndrome is due to a defect in removal of endogenous plasma triglyceride (8) .
To determine if a rise in plasma lipoprotein concentration is caused primarily by increased production or by decreased removal, it is necessary to compare turnover rate with concentration through a wide range of these variables in a defined human population. At present, we find no data in normal or abnormal populations that permit such an analysis. However, we have recently devised and validated a model for triglyceride turnover in man using isotopically labeled glycerol as a precursor for plasma triglyceride (19) . We report here our use of these techniques in a study of the relationship between concentration and turnover rate of plasma triglyceride in a group of human subjects. The results demonstrate a close dependency of these two variables under a wide variety of experimental conditions.
Methods
Subj ects selected for study were either assumed to have no abnormality of lipid metabolism or were expected to have wide variations of triglyceride concentrations in response to weeks of ingestion of either high or low fat diets. Relevant clinical features of the 12 patients are 1826 extracted from these lipoproteins (19) , and the triglycerides were isolated by thin layer chromatography, their concentration and radioactivity were determined, and specific activities were calculated.
Calculations. A previous report from this laboratory has validated a two-compartment, nonrecycling model of hepatic and plasma Sf > 20 triglyceride turnover in man (19) . Turnover rates are calculated from the slope of the specific activity disappearance curve of endogenously labeled Sf > 20 plasma triglyceride after the intravenous injection of isotopically labeled glycerol. The validity of this calculation is based upon our previous discovery of the rate-determining role in the two pool system of plasma Sf > 20 triglyceride fractional turnover rates (19) . These studies were performed while plasma triglyceride concentrations were constant. Therefore, turnover rate of plasma triglyceride is equal to plasma triglyceride flux from liver into plasma. These data then allow one to define the mathematical relationship of plasma triglyceride concentration and turnover rate that exists in the population under study.
Results
The relationship between plasma Sf > 20 triglyceride concentration and turnover rate for each patient studied is tabulated in Table II , and portrayed in Figure 1 . It can be seen that plasma triglyceride concentration in nine to eleven de- (Figure 2 ). The slope of the best fit line through these data ( Figure 2) Five paired studies were designed to investigate the effect of chlorpropamide on triglyceride turnover. Results showed that turnover rate, when measured after several weeks of chlorpropamide treatment, was always lower than in previous studies on the same diet (Table II) . It was not possible to discern any systematic deviation of these data from the general shape of the curve of Figure 1 .
Also, there were six comparisons of high and low fat diets (Table II) . In one subject (J.P.), little difference in Sf > 20 triglyceride concentration or turnover was noted. In the remaining five comparisons, lower concentrations were present in the high fat diet; all pairs but one (C.P.) resulted in distinctly lower turnover rates on the high fat diet.
Discussion
The concentration of any solute in plasma will tend to rise and fall as its flux in or out of plasma is varied. A rise in plasma concentration to a new steady state level can only result from either increased entry rate or decreased removal rate of the solute in question. During nonsteady state conditions, as the solute concentration is rising, its removal rate from the plasma must be less than its entry rate. Eventually, efflux will again equal influx, and solute concentration will now be stable at its higher plasma level. Consequently, whenever solute concentration has increased, removal mechanisms have failed to maintain homeostasis. However, it does not follow that a primary defect in solute removal is responsible for the rise in concentration. To establish the presence of such removal defects it is necessary to find a plasma concentration of Sf > 20 triglyceride associated with a lower turnover rate than is normally present for that concentration. Our results (Figures 1 and 2 ) argue against the existence of primary removal defects because they deny the presence of two or more distinct population groups differing only in plasma triglyceride removal rate. In fact, the homogeneity of the fit of the experimental data to a single curve (Figures 1 and 2) indicates that the population studied was remarkably homogeneous in triglyceride removal efficiency. In these studies, higher plasma Sf > 20 triglycerides were generally accompanied by higher turnover rates of this substance (Table II, Figure 1 ). At each increment in plasma concentration more triglycerides were being made and secreted into plasma and more triglycerides were being removed from plasma. Production and removal were equal since each experimental point represented a steady state in concentration. Higher plasma concentration occurred because removal mechanisms did not keep pace with increased production, but increased production was the primary cause for the rise in plasma Sf > 20 triglyceride concentration.
This does not mean that certain individuals will not demonstrate important variations from the relationship that has been described, and in these instances hypertriglyceridemia may well result from primary removal defects. For example, it seems quite likely that patients with "fat-induced hypertriglyceridemia" would demonstrate an elevated level of plasma triglyceride in association with low turnover rates. Furthermore, the recent report of decreased plasma postheparin lipolytic activity in patients with myxedema (25) suggests that hypertriglyceridemia in this disorder may also result from lessened removal efficiency. However, in contrast to these and other unusual disorders, the patients we studied should be more typical of the general population. All of our subjects were consuming constant diets, their body weights were stable, and individuals with fasting hyperglycemia or with fat-induced hypertriglyceridemia were excluded. Within this group of patients varying from clearly normal to abnormal in plasma triglyceride concentration, turnover rates were determined at different triglyceride levels that were varied by dietary alterations or by administration of chlorpropamide. By these means some of the group were raised or lowered in Sf > 20 triglyceride concentration and in turnover rate to levels that bracketed the triglyceride concentrations of others of the group. This interlocking of responses through the wide range of observed concentrations suggests that a larger sample of the general population would follow the observed relationship between plasma triglyceride concentration and turnover rate (Figures 1 and 2) .
The data relating plasma triglyceride concentration to turnover rate were presented in the nomenclature of the Michaelis-Menten formulation, not because the precise enzymatic nature of clearing has been identified, but because the experimental data are consistent with such kinetics. The function relating concentration to turnover rate in these studies is clearly explicable by a saturable system, perhaps an enzyme dependent mechanism, and cannot, by its nonlinearity, be attributed to simple diffusion. Moreover, there is much evidence in numerous mammalian species that an enzymatic process is responsible for clearing triglyceride of either chylomicrons (26) or of low density lipoproteins (27) . Although other enzymes have not been excluded (17) , the major enzyme in this reaction is very likely lipoprotein lipase, an enzyme first isolated and characterized by Korn (28) . This enzyme is found in many tissues, but it is in highest concentration in adipose tissue (29, 30) or heart muscle (29) Furthermore, the function relating these two variables is consistent with a saturable, and possibly enzyme dependent, mechanism for removal of this lipoprotein triglyceride from plasma. Since the clearing efficiency within this group seems remarkably homogeneous, increased production rather than a triglyceride removal defect is therefore responsible for rising plasma Sf > 20 triglyceride concentration. Finally, the low substrate concentration at 4 maximal turnover rate of this system (118 mg Sf > 20 triglyceride per 100 ml plasma) attests to the ready saturability of triglyceride removal mechanisms in man.
